TriSalus Life Sciences (TLSIW) Shares Outstanding (2020 - 2026)

TriSalus Life Sciences (TLSIW) has 7 years of Shares Outstanding data on file, last reported at $61.4 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 90.3% year-over-year to $61.4 million; the trailing twelve-month figure through Mar 2026 stood at $61.4 million (up 90.3% YoY), and the FY2025 full-year result was $50.0 million, up 59.84% from the prior year.
• Shares Outstanding for Q1 2026 stood at $61.4 million, up from $50.0 million in the prior quarter.
• Across five years, Shares Outstanding topped out at $61.4 million in Q1 2026 and bottomed at $298725.0 in Q1 2022.
• The 5-year median for Shares Outstanding is $26.8 million (2024), against an average of $23.7 million.
• The widest annual swing landed in 2022, when Shares Outstanding sank 95.22%; it then surged 8117.67% in 2023.
• A 5-year view of Shares Outstanding shows it stood at $347926.0 in 2022, then soared by 7491.62% to $26.4 million in 2023, then grew by 18.42% to $31.3 million in 2024, then jumped by 59.84% to $50.0 million in 2025, then rose by 22.83% to $61.4 million in 2026.
• The last three Shares Outstanding figures came in at $61.4 million (Q1 2026), $50.0 million (Q4 2025), and $49.9 million (Q3 2025), per Business Quant data.

Peer Comparison